Back to results
US 2024/0197829 A1Published application
Treatment of neuropathic corneal pain with ngf
AssigneesDompé Farmaceutici S.P.A., Tufts Medical Center, Inc.
InventorsPedram HAMRAH, Flavio MANTELLI
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods of treating neuropathic corneal pain (NCP) comprising administration of nerve growth factor (NGF).
Claims14
1-10. (canceled)
A method of treating neuropathic corneal pain (NCP) in a subject in need thereof, comprising administration of a composition comprising NGF.
Dependencies are inferred from the claim text.